Skip to Content

SEND Conversion

 SEND (Standard for Exchange of Nonclinical Data) is a CDISC standardised format required by the FDA for the submission of preclinical study data. It replaces traditional PDF study reports with structured datasets, enhancing data consistency, regulatory compliance, and review efficiency.

AUXO provides specialised SEND data generation services to support sponsors and CROs in meeting FDA submission requirements. Our expertise includes extracting, transforming, and validating data from multiple sources, such as LIMS and study reports, ensuring full compliance with CDISC SEND Implementation Guide (SENDIG) and FDA validation rules.

Contact us

Discover Seamless Non-clinical Data Standardisation with our SEND Services

Transforming Data into Compliance, One Standard at a Time

What we do?

We understand the importance of accurate and consistent data in the drug development process. Our SEND services make sures to deliver the SEND packages with quality.

1. Data Standardisation

Our skilled professionals are well-versed in CDISC standards and will transform your raw nonclinical data into compliant SEND datasets. We create SEND datasets for a variety of study types, including pharmacokinetic, toxicology, and safety studies.

2. Validation and Quality Control

Quality is our top priority. We perform rigorous validation checks on SEND datasets against FDA Business rules, FDA validation rules and CDISC Compliance rules to identify any inconsistencies, errors, or missing information. We conduct a thorough QC review against study reports to ensure that SEND datasets are consistent with the study report. Our quality control processes, guarantee that your data is accurate, reliable, and ready for regulatory submission.

3. Supported SENDIG Versions

Our expertise encompasses a range of SEND Implementation Guide (IG) versions, including:

  • SENDIG 3.1 and 3.1.1
  • SENDIG-Animal Rule v1.0
  • SENDIG-DART v1.1 and v1.2
  • SENDIG-Genetox v1.0

4. Custom Domain Support

We're equipped to handle data standardisation for domains that may currently required to be standardised in custom domains, such as:

  • ADA (Anti-Drug Antibodies).
  • Nervous System Findings.
  • Dermal and Ocular Measurements.

5.Delivered SEND Package

When you choose us, your delivered SEND package includes:

  • Standardised SEND datasets in SAS Transport Files (XPT format).
  • Define.xml.
  • Nonclinical Study Data Reviewer’s Guide (nsdrg).
  • Pinnacle21 validation reports.

What Is SEND?

 

The Standard for Exchange of Nonclinical Data (SEND) is an implementation of the CDISC Standard Data Tabulation Model (SDTM) for nonclinical studies. SEND provides a standard format for presenting nonclinical data, ensuring consistency in the organisation and integration of study information. This facilitates the process of submitting nonclinical data to regulatory bodies, leading to greater coherence in presentation and transparency in the assessment and analysis of the information. Ultimately, SEND enables a more efficient and streamlined journey towards regulatory approval.

 What Is SEND Scope?

SENDIG's Core Focus: Designed for various study types, including:

  • Single-dose general toxicology.
  • Repeat-dose general toxicology.
  • Carcinogenicity studies
  • Respiratory and cardiovascular testing in safety pharmacology studies.

Diverse Study Support: Additional SENDIG versions cater to specific study types:

  • SENDIG-DART v1.1 and 1.2: Focuses on DART studies, particularly.
  • embryo-fetal development and juvenile animal toxicity.
  • SENDIG-AR v1.0: Supports data submission under the Animal Rule.

Ensuring Conformance and Quality:

  • Conformance rules ensure generated data structures conform to standards.
  • These rules identify and codify conformance criteria and case logic from the SENDIG.
  • Supports development of quality processes and tools for data integrity.

When is SEND Data Standardisation Required?

Understanding when SEND (Standard for Exchange of Nonclinical Data) data standardisation is required is crucial for compliance with regulatory agencies' submission requirements. The table below from FDA Standards catalog provides a summarised overview of when SEND is mandatory for different types of submissions, along with variations in date requirements for CBER (Center for Biologics Evaluation and Research) and CDER (Center for Drug Evaluation and Research).

The FDA's mandate for the implementation of the FDA SEND 3.0 on December 17, 2017, necessitated the submission of regulatory documents in an electronic formatSubsequently, on March 15, 2019, the scope expanded with the requirement of SEND 3.1 for IND studies, encompassing Safety  Pharmacology, particularly for cardiovascular and respiratory studies. Additionally, beginning March 15, 2023, CBER enforced the Standard for the Exchange of Nonclinical Data (SEND), further extending the regulatory requirements.

Our team is well-versed in the evolving SEND regulations and can guide you through the intricacies of compliance. Contact us today to learn how our expert services can help you navigate the changing landscape of nonclinical data standardisation.

Why to choose AUXO?

AUXO simplifies SEND compliance with expertise, precision, and efficiency. Our team specialises in transforming nonclinical data into FDA and globally compliant formats, ensuring accuracy and submission readiness. From data mapping to final validation, we provide end-to-end solutions tailored to your needs. Using advanced tools, we streamline the process while maintaining rigorous quality control. With a proven track record of successful submissions across diverse therapeutic areas, we help clients achieve timely approvals. Our client-focused approach ensures transparent communication and reliable support every step of the way. Trust AUXO to deliver SEND-compliant datasets that meet global standards, accelerating your path to market success. 

15+

Years of Experience

Team of experts delivering safety and regulatory submissions. 

500+

SEND Submissions

Experienced team ensuring regulatory compliance with highest accuracy.

Global Network

We bring extensive global experience in regulatory compliance, ensuring industry-leading expertise across international markets.

Blogs

Our latest content

Check out what's new in our company !

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.